Characterization of a carbapenem- and colistin-resistant Enterobacter cloacae carrying Tn6901 in bla_NDM-1 genomic context

References

• Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Carbapenems: past, present, and future. Antimicrob Agents Chemother. 2011;55(11):4943–4960. doi:10.1128/AAC.00296-1121859938
   PubMed Web of Science ®Google Scholar
• Nordmann P, Poirel L. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect. 2014;20. doi:10.1111/1469-0691.12742
   Web of Science ®Google Scholar
• Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53(12):5046–5054. doi:10.1128/AAC.00774-0919770275
   PubMed Web of Science ®Google Scholar
• Liu Z, Wang Y, Walsh TR, et al. Plasmid-mediated novel blaNDM-17 gene encoding a carbapenemase with enhanced activity in a sequence type 48 Escherichia coli strain. Antimicrob Agents Chemother. 2017;61(5). doi:10.1128/AAC.02233-16.
   Google Scholar
• Poirel L, Bonnin RA, Boulanger A, Schrenzel J, Kaase M, Nordmann P. Tn125-related acquisition of bla(NDM)-like genes in Acinetobacter baumannii. Antimicrob Agents Chemother. 2012;56(2):1087–1089. doi:10.1128/AAC.05620-1122143526
   PubMed Web of Science ®Google Scholar
• American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388–416. doi: 10.1164/rccm.200405-644ST.15699079
   PubMed Web of Science ®Google Scholar
• Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40(9):1333–1341. doi:10.1086/42932315825037
   PubMed Web of Science ®Google Scholar
• Catry B, Cavaleri M, Baptiste K, et al. Use of colistin-containing products within the European Union and European Economic Area (EU/EEA): development of resistance in animals and possible impact on human and animal health. Int J Antimicrob Agents. 2015;46(3):297–306. doi:10.1016/j.ijantimicag.2015.06.00526215780
   PubMed Web of Science ®Google Scholar
• Bialvaei AZ, Kafil HS. Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin. 2015;31(4):707–721. doi:10.1185/03007995.2015.101898925697677
   PubMed Web of Science ®Google Scholar
• Manohar P, Shanthini T, Ayyanar R, et al. The distribution of carbapenem- and colistin-resistance in Gram-negative bacteria from the Tamil Nadu region in India. J Med Microbiol. 2017;66(7):874–883. doi:10.1099/jmm.0.00050828671537
   PubMed Web of Science ®Google Scholar
• Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev. 2017;30(2):557–596. doi:10.1128/CMR.00064-1628275006
   PubMed Web of Science ®Google Scholar
• Musil I, Jensen V, Schilling J, Ashdown B, Kent T. Enterobacter cloacae infection of an expanded polytetrafluoroethylene femoral-popliteal bypass graft: a case report. J Med Case Rep. 2010;4:131. doi:10.1186/1752-1947-4-13120459698
   PubMedGoogle Scholar
• Sanders WE, Sanders CC. Enterobacter spp.: pathogens poised to flourish at the turn of the century. Clin Microbiol Rev. 1997;10(2):220–241.9105752
   PubMed Web of Science ®Google Scholar
• Lee Y, Choi H, Yum JH, et al. Molecular mechanisms of carbapenem resistance in Enterobacter cloacae clinical isolates from Korea and clinical outcome. Ann Clin Lab Sci. 2012;42(3):281–286.22964616
   PubMed Web of Science ®Google Scholar
• Kiedrowski LM, Guerrero DM, Perez F, et al. Carbapenem-resistant Enterobacter cloacae isolates producing KPC-3, North Dakota, USA. Emerg Infect Dis. 2014;20(9):1583–1585. doi:10.3201/eid2009.14034425153967
   PubMed Web of Science ®Google Scholar
• Wilson BM, El Chakhtoura NG, Patel S, et al. Carbapenem-resistant Enterobacter cloacae in patients from the US Veterans Health Administration, 2006–2015. Emerg Infect Dis. 2017;23(5):878–880. doi:10.3201/eid2305.16203428418318
   PubMed Web of Science ®Google Scholar
• Norgan AP, Freese JM, Tuin PM, Cunningham SA, Jeraldo PR, Patel R. Carbapenem- and colistin-resistant Enterobacter cloacae from Delta, Colorado, in 2015. Antimicrob Agents Chemother. 2016;60(5):3141–3144. doi:10.1128/AAC.03055-1526883705
   PubMed Web of Science ®Google Scholar
• Huang L, Wang X, Feng Y, Xie Y, Xie L, Zong Z. First identification of an IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae in China. Ann Clin Microbiol Antimicrob. 2015;14:51. doi:10.1186/s12941-015-0113-126607057
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing – 28th Edition. CLSI Document M100-28. Wayne (PA): CLSI; 2018.
   Google Scholar
• European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical Breakpoints – bacteria v9.0. 2019 Available from: http://www.eucast.org/clinical_breakpoints/. Accessed 118, 2019.
   Google Scholar
• Zankari E, Hasman H, Cosentino S, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012;67(11):2640–2644. doi:10.1093/jac/dks26122782487
   PubMed Web of Science ®Google Scholar
• Belén A, Pavón I, Maiden MCJ. Multilocus sequence typing. Methods Mol Biol (Clifton, NJ). 2009;551:129–140.
   Google Scholar
• Varani AM, Siguier P, Gourbeyre E, Charneau V, Chandler M. ISsaga is an ensemble of web-based methods for high throughput identification and semi-automatic annotation of insertion sequences in prokaryotic genomes. Genome Biol. 2011;12(3):R30. doi:10.1186/gb-2011-12-3-r3021443786
   PubMed Web of Science ®Google Scholar
• Afgan E, Baker D, van den Beek M, et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update. Nucleic Acids Res. 2016;44(W1):W3–W10. doi:10.1093/nar/gkw34327137889
   PubMed Web of Science ®Google Scholar
• Carattoli A, Zankari E, Garcia-Fernandez A, et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 2014;58(7):3895–3903. doi:10.1128/AAC.02412-1424777092
   PubMed Web of Science ®Google Scholar
• Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet. 1998;351(9105):797–799. doi:10.1016/S0140-6736(97)07322-49519952
   PubMed Web of Science ®Google Scholar
• Tran JH, Jacoby GA, Hooper DC. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother. 2005;49(1):118–125. doi:10.1128/AAC.49.1.118-125.200515616284
   PubMed Web of Science ®Google Scholar
• Jacoby GA, Walsh KE, Mills DM, et al. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob Agents Chemother. 2006;50(4):1178–1182. doi:10.1128/AAC.50.4.1178-1182.200616569827
   PubMed Web of Science ®Google Scholar
• Poirel L, Lagrutta E, Taylor P, Pham J, Nordmann P. Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother. 2010;54(11):4914–4916. doi:10.1128/AAC.00878-1020823289
   PubMed Web of Science ®Google Scholar
• Zurfluh K, Poirel L, Nordmann P, Klumpp J, Stephan R. First detection of Klebsiella variicola producing OXA-181 carbapenemase in fresh vegetable imported from Asia to Switzerland. Antimicrob Resist Infect Control. 2015;4(1):38. doi:10.1186/s13756-015-0080-526448862
   PubMed Web of Science ®Google Scholar
• Murata T, Ohnishi M, Ara T, et al. Complete nucleotide sequence of plasmid Rts1: implications for evolution of large plasmid genomes. J Bacteriol. 2002;184(12):3194–3202.12029035
   PubMed Web of Science ®Google Scholar
• Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–168. doi:10.1016/S1473-3099(15)00424-726603172
   PubMed Web of Science ®Google Scholar